Scientific Program download
Click here for Speaker AbstractsThursday October 22, 2009, MaRS Auditorium |
||||
8:30 - 9:00 am | Registration | |||
9:00 – 9:05 am | Opening remarks Cheryl Arrowsmith (Chief Scientist, SGC Toronto) |
|||
9:05 – 10:35 am | Session 1: “Chromatin Signaling Mechanisms and Gene Expression” Chair: Peter Cheung (Ontario Cancer Institute, Toronto, Canada) |
|||
9:05 am | Brad Cairns (Huntsman Cancer Institute, University of Utah, Utah, USA) Germline Chromatin: Concepts Shared Between Germ Cells and ES Cells |
|||
9:35 am | Jerry Workman (Stowers Institute for Medical Research, Kansas City, MO, USA) The ATAC Histone Acetyltransferase Complex Signals for the Inhibition of the MAP Kinase Cascade Through its MoaE Subunit | |||
10:05 am | Robert Martienssen (Cold Spring Harbor, NY, USA) Copying and Reprogramming of Heterochromatin with RNAi | |||
10:35 am | Coffee Break | |||
11:00 – 12:30 pm | Session 2: "Environmental Modulation of Epigenetic States I"
Chair: Tim Willson (GSK, Research Triangle Park, NC, USA) |
|||
11:00 am | Arturas Petronis (CAMH, Toronto, Canada) Epigenetics of Major Psychosis |
|||
11:30 am | Ian Adcock (Imperial College London, UK) Chromatin Biology, Inflammation and Lung Disease Watch Video [part 1] [part 2] [part 3] |
|||
12:00 am | Paolo Sassone-Corsi (University of California, Irvine, CA, USA) Epigenetics and Metabolism: the Circadian Clock Connection Watch Video [part 1] [part 2] [part 3] [part 4] |
|||
12:30 pm | Lunch | |||
2:00 – 4:00 pm | Session 3: "Environmental Modulation of Epigenetic States II" Chair: Udo Oppermann (SGC Oxford, Oxford, UK) |
|||
2:00 pm | Gioacchino Natoli (European Institute of Oncology, Milan, Italy) The Epigenome and the Transcriptional Control of Innate Immunity and Inflammation | |||
2:30 pm | Vincenzo Pirrotta (Rutgers University, NJ, USA) Polycomb Targets and Alternative Chromatin States | |||
3:00 pm | Michael Meaney (McGill University, Montreal, Canada) Epigenetic Programming of Behavior and Physiology | |||
3:30 pm | Rama Natarajan (City of Hope, Duarte, CA, USA) Epigenetic Mechanisms Underlying Inflammatory Gene Expression Under Diabetic Conditions | |||
4:00 pm | Break and Poster Set up | |||
4:30 - 6:00 pm | Poster Session & Wine and Cheese Reception | |||
Friday October 23, 2009, MaRS Auditorium |
||||
9:00 – 10:30 pm | Session 4: “Signaling Mechanisms in Chromatin Biology” Chair: Jinrong Min (SGC Toronto, Toronto, Canada) |
|||
9:00 am | Xiaodong Cheng (Emory University School of Medicine, Atlanta, GA, USA) Epigenetic Link Between DNA Methylation and Histone Modifications | |||
9:30 am | Mark Bedford (M. D. Anderson Cancer Center, Texas, USA) TDR3 is an Effector Molecule for CARM-Generated Methyl Motifs | |||
10:00 pm | Xiang-Jiao Yang (Goodman Cancer Centre, McGill University, Montreal, Canada) Different Regulatory Mechanisms for Histone Acetyltransferases and Deacetylases | |||
10:30 am | Coffee break | |||
11:00 – 12:30 pm | Session 5: "Epigenetic Mechanisms in Development and Disease"
Chair: Gordon Keller (Ontario Cancer Institute, Toronto, Canada) |
|||
11:00 am | Bing Ren (University of California, San Diego, CA, USA) Epigenomic Landscapes of Pluripotent and Lineage-Committed Human Cells |
|||
11:30 am | Antoine Peters (Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland) Transgenerational Epigenetic Control of Early Mouse Development |
|||
12:00 pm | Christopher Wynder (McMaster Stem Cell and Cancer Research Institute, Hamilton, Canada) Regulation of H3K4 Demethylation Controls Neural Differentiation; a Molecular Investigation of Complex Neuro-Developmental Disorders |
|||
12:30-2:00 pm | Lunch | |||
2:00 – 4:30 pm | Session 6: "Harnessing the Epigenome for Therapy: Target Validation and Biomarkers" Chair: Chas Bountra (SGC Oxford, Oxford, UK) |
|||
2:00 pm | Sam Aparicio (BC Cancer Research Centre, Vancouver, BC, Canada) MLL5 Function in Hematopoeisis and Leukemia; Implications for Therapy |
|||
2:30 pm | Victoria Richon (Epizyme Inc., Cambridge, MA, USA) Targeting Histone Deacetylases: Development of Vorinostat for the Treatment of Cancer |
|||
3:00 pm | Stephen Frye (Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA) Promoting Illiteracy in Epigenetics: Antagonists of the Readers of the Epigenetic Code |
|||
3:30 pm | Shohei Koide (University of Chicago, IL, USA) Synthetic Binding Proteins: New Tools for Epigenetics |
|||
4:00 pm | Speaker to be Determined | |||
4:30 pm | Concluding remarks | |||
* Talk titles in Italics are subject to change |